Status:

COMPLETED

FATA: Randomized Study on Facilitated Angioplasty With Tirofiban or Abciximab

Lead Sponsor:

University of Bologna

Conditions:

Acute Myocardial Infarction

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

The elective("standard of care") treatment of ST - elevation acute myocardial infarction (STEMI) currently consists of primary angioplasty with stent implantation during administration of Abciximab, a...

Detailed Description

The Facilitated Angioplasty with Tirofiban or Abciximab Study (FATA Study) is a prospective multicentre study, randomized in 2 groups (high dose Tirofiban or Abciximab), on a sample of 700 patients wi...

Eligibility Criteria

Inclusion

  • STEMI diagnosed due to the presence of chest pain lasting at least 20 minutes and less than 6 hours, associated with elevation of the ST segment \>1 mm in at least 2 adjacent leads
  • Informed consent
  • Age \> 18 years

Exclusion

  • Complete left bundle branch block
  • Previous myocardial infarction at the same site
  • Post-anoxic coma
  • Known thrombocytopenia or leucopenia
  • Severe hepatic dysfunction;
  • Previous episodes of hemorrhagic diathesis or allergy to ASA or thienopyridine;
  • Recent major surgery (\< 3 months before)
  • Associated diseases that involve short life expectancy (\< 2 years);
  • Arterial hypertension (AP \>180/110);
  • Positive case history for stroke within the previous 30 days;
  • Positive case history for intracranial disease (aneurysm, arterovenous malformation);
  • Major trauma within the previous six weeks;
  • A clinical condition which, in the doctor's opinion, could interfere with the patient's full participation in the study;
  • Pregnancy or fertile age;
  • Anticoagulant therapy with dicumarol with INR \> 2;
  • Renal insufficiency (creatinine \> 3.0 mg/dl) known at the time of the study;
  • Previous treatment with thrombolytics (within the previous 48 hours);
  • Participation in other studies in progress.

Key Trial Info

Start Date :

June 1 2003

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2007

Estimated Enrollment :

692 Patients enrolled

Trial Details

Trial ID

NCT00383136

Start Date

June 1 2003

End Date

September 1 2007

Last Update

January 16 2008

Active Locations (6)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (6 locations)

1

Divisione Di Cardiologia, Ospedale Maggiore

Bologna, BO, Italy, 40100

2

Laboratorio Di Emodinamica, Istituto Di Cardiologia, Azienda Ospedaliera S.Orsola Malpighi

Bologna, BO, Italy, 40138

3

Azienda Ospedaliera Universitaria Policlinico

Modena, MO, Italy, 41100

4

Divisione Di Cardiologia, Ospedale S.Maria Nuova

Reggio Emilia, RE, Italy, 42100

FATA: Randomized Study on Facilitated Angioplasty With Tirofiban or Abciximab | DecenTrialz